Clinical and preclinical studies have proved that the drug prevents the penetration of the virus into cells with its subsequent defeat and has an immunomodulatory effect, which is aimed at increasing humoral immunity.
The components of the drug have anticoagulant, antioxidant, cytoprotective, immunomodulatory effects, and also provide antibacterial and antiviral activity.
Clinical studies have shown high efficacy in 92% of patients and no undesirable side effects were noted in the study group.
On November 13, 2020, the trademark of the drug was registered by the Intellectual Property Agency. On February 14, 2022, the Ministry of Health of the Republic of Uzbekistan registered "Antikovir" as an antiviral drug recommended for the treatment and prevention of coronavirus infection and postcovid syndrome.
Uzbekistan has developed a drug against coronavirus - "Antikovir"
A new remedy for coronavirus has been developed at the Institute of Pharmaceutical Education and Research of Uzbekistan. Through the joint efforts of pharmacists and pharmacologists of this institute, a multicomponent drug "Antikovir" was created on the basis of natural and mineral sources, through biotechnological and chemical synthesis.
New international train service to be launched on the Tashkent–Astrakhan route
- Uzbekistan showcased over 300 films at international content market in Dubai
- Uzbekistan and Oman adopt a substantial package of bilateral documents
- Uzbekistan and Oman elevate relations to a strategic partnership
- In Uzbekistan, one-year preparation of children for school can become a mandatory stage of general secondary education
- Uzbekistan has approved the procedure for conducting competitions for grants in the field of culture and art
Uzbek citizens who find themselves in a difficult life situation in the Russian Far East have been assisted in returning to their homeland
- How much cash can be imported into and out of Uzbekistan: border crossing rules
- Measures outlined to improve the labor migration system
- President of Uzbekistan attends Central Asian Leaders’ Meeting under the Aqaba Process
- President inspects restoration work at the Kosh-Madrasah ensemble
- Intil Center provides targeted training for employment abroad